2025年中国脑机接口行业细分产品市场分析 非侵入式脑机接口是市场上最为普遍的消费级设备【组图】

Group 1 - The core viewpoint of the article highlights the development prospects and investment opportunities in the brain-computer interface (BCI) industry, particularly focusing on the segmentation of the market into invasive and non-invasive categories [1][9]. - The invasive BCI market is still in its early stages compared to the non-invasive market, primarily due to higher technical requirements and fewer companies involved in development [7][9]. - The article identifies key companies in the invasive BCI sector, such as JieTi Medical, which is set to complete its first human clinical trial by March 2025, and Brain Tiger Technology, which has achieved significant milestones in motion decoding experiments [8][9]. Group 2 - Invasive BCIs offer advantages such as precise measurement of neuronal impulses, high signal-to-noise ratio, and high resolution, but they also come with disadvantages like the risk of immune response and surgical trauma [5]. - The capital focus on invasive BCI has increased significantly, with financing share rising from 7% (2015-2019) to 44% (2020-2023), although it is expected to decrease to 27% in 2024-2025 [9]. - Non-invasive BCIs are the most common consumer-grade devices in the market, with numerous companies like QiangNerve Technology and RouLing Technology leading in this segment [11][12].